For Anderson family, an early bet on SMA gene therapy
NEW YORK (Reuters) – When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly […]
Health News
U.S. judge blocks Mississippi ‘heartbeat’ abortion ban
FILE PHOTO: Abortion-rights campaigners attend a rally against new restrictions on abortion passed by legislatures in eight states including Alabama and Georgia, in New York […]
FDA approves $2M medicine, most expensive ever
This photo provided by Novartis shows Zolgensma, the one-time gene therapy that will cost $2.125 million US to treat a rare condition called spinal muscular […]
Seniors who feel their life has purpose may live longer
(Reuters Health) – Seniors who feel their life has purpose may be less likely to die from heart, circulatory and digestive diseases and more likely […]
Novartis $2 million gene therapy for rare disorder is world’s most expensive drug
ZURICH/NEW YORK – Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause […]
Novartis’ breast cancer treatment wins FDA approval
The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food […]
Big drug distributor pays $22 million to settle U.S. opioid charges
(Reuters) – Morris & Dickson Co, one of the largest U.S. wholesale drug distributors, agreed to pay $22 million in civil penalties to settle U.S. […]
U.S. says big drug distributor to pay $22 million in penalties over opioids
(Reuters) – Morris & Dickson Co, the largest privately owned U.S. wholesale drug distributor, agreed to pay $22 million in civil penalties to resolve claims […]
U.N. names emergency coordinator to boost fight against Ebola in Congo
A Congolese woman and her children who are suspected Ebola patients sit at the Ebola treatment centre in Butembo, Congo, in March. (Baz Ratner/Reuters) The […]
U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorder
ZURICH/NEW YORK – Swiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death […]